A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.
Gynecologic Oncology(2018)
Abstract
•Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new form of intraabdominal drug delivery.•Patients were treated with PIPAC in a phase I dose escalation study.•No dose limiting toxicities were found after 3 escalation steps.•PIPAC with doxorubicin (2.1 mg/m2) and cisplatin (10.5 mg/m2) may be safely applied into the abdomen.
MoreTranslated text
Key words
Ovarian cancer,Intraperitoneal chemotherapy,PIPAC,Pressurized chemotherapy,Cisplatin,Doxorubicin
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined